4-[(E)-2-(4-methoxyphenyl)diazenyl]-1H-pyrazole-3,5-diamine manufacturers
- ILK-IN-3
-
- $30.00 / 1mg
-
2024-11-19
- CAS:6975-75-3
- Min. Order:
- Purity: 99.69%
- Supply Ability: 10g
|
| 4-[(E)-2-(4-methoxyphenyl)diazenyl]-1H-pyrazole-3,5-diamine Basic information |
Product Name: | 4-[(E)-2-(4-methoxyphenyl)diazenyl]-1H-pyrazole-3,5-diamine | Synonyms: | 3-amino-4-[(E)-2-(4-methoxyphenyl)diazenyl]-1H-pyrazol-5-ylamine;4-[(E)-2-(4-methoxyphenyl)diazenyl]-1H-pyrazole-3,5-diamine;ILK-IN-3;1H-Pyrazole-3,5-diamine, 4-[2-(4-methoxyphenyl)diazenyl]-;antitumor,Integrin,inhibit,ILK,Inhibitor,ILK IN 3,ILKIN3;ILK-IN-3, 10 mM in DMSO | CAS: | 6975-75-3 | MF: | C10H12N6O | MW: | 232.24 | EINECS: | | Product Categories: | | Mol File: | 6975-75-3.mol | ![4-[(E)-2-(4-methoxyphenyl)diazenyl]-1H-pyrazole-3,5-diamine Structure](CAS/20180808/GIF/6975-75-3.gif) |
| 4-[(E)-2-(4-methoxyphenyl)diazenyl]-1H-pyrazole-3,5-diamine Chemical Properties |
storage temp. | Keep in dark place,Inert atmosphere,Store in freezer, under -20°C | solubility | DMSO: 83.33 mg/mL (358.81 mM) | form | Solid | color | Light yellow to yellow |
| 4-[(E)-2-(4-methoxyphenyl)diazenyl]-1H-pyrazole-3,5-diamine Usage And Synthesis |
Biological Activity | QLT0267 is an orally active, potent and selective integrin-linked kinase (ILK) inhibitor (IC50 = 26 nM; selectivity: >1000-fold over CK2, CSK, DNA-PK, PIM1, PKB/AKT, PKC, >100-fold over ERK1, GSK3β, LCK, PKA, p70S6K, and RSK1/QLT, >10-fold over CDK1/2/5) th at inhibits ILK-dependent cellular signaling (IC50 in 2h = 1 μM against 20 nM EGF-induced pAKT Ser473 phosphorylation in Hth74 cells). QLT0267 treatment causes thyroid cancer cell cycle arrest and apoptosis, leading to anti-proliferation efficacy in cultures (IC50 <6 μM; NPA187, DRO, and K4 cell lines) and in mice in vivo (DRO xenografts-derived tumor growth; 50-100 mg/kg via daily p.o.). |
| 4-[(E)-2-(4-methoxyphenyl)diazenyl]-1H-pyrazole-3,5-diamine Preparation Products And Raw materials |
|